- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06322043
Evaluation of Safety of Filler Injection in Subcutaneous Tissues
March 13, 2024 updated by: Volumina Medical S.A.
A Single-Arm Pilot Study to Evaluate the Safety of Adipearl Injection in the Subcutaneous Tissues of Adults
Adipearl is an injectable filler intended to be injected subcutaneously.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Crans-Montana, Switzerland
- Summit Clinic
-
Contact:
- Summit Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Subject having given freely and expressly informed consent;
- Subject deemed by the Investigator to be medically fit for injection of the product;
- Female or male subjects aged 22 to 65 years (inclusive);
Exclusion Criteria:
- Pregnant or nursing woman or planning a pregnancy during the study.
- Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
- Subject participating to another research study.
- Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Volume correction with Investigational Device
Subjects will be injected subcutaneously with the Investigational Device to correct volume deficiencies.
|
Injection of the investigational device in subcutaneous tissue.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety of Investigational Medical Device
Time Frame: 6-Months
|
Collection of Injection Site Reactions and Adverse Events during the study.
|
6-Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
March 13, 2024
First Submitted That Met QC Criteria
March 13, 2024
First Posted (Actual)
March 20, 2024
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- VM-APFB-1023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Volume Deficiency
-
Galderma R&DCompletedVolume Deficiency of the MidfaceGermany, Italy, United Kingdom
-
Derming SRLCompletedMalar and Sub-malar Volume DeficiencyItaly
-
Biopolimeri Srl1MedRecruitingDermal Filler | Volume Deficiency of the MidfaceItaly
-
Volumina Medical S.A.RecruitingMid-face Volume DeficiencySweden
-
AllerganCompletedMid-face Volume DeficiencyAustralia
-
Galderma R&DCompletedVolume Deficiency of the MidfaceUnited States
-
Derming SRLCompletedMalar and Sub-malar Volume DeficiencyItaly
-
Galderma R&DActive, not recruitingPhotodamaged Skin | Volume Deficiency of the MidfaceUnited States
-
Laboratoires VivacyAvania B.V.; Canfield Scientific Inc.Active, not recruitingAging | Aesthetics | Volume Deficiency in the Mid-FaceFrance
-
Seoul National University HospitalCompletedPlasma Volume | Tidal VolumeKorea, Republic of
Clinical Trials on Adipearl
-
Volumina Medical S.A.RecruitingMid-face Volume DeficiencySweden